Your trials are leaking money, and your sites know where
Join us for an in-depth conversation on effective strategies for growing your site within today’s evolving clinical research landscape. Hear from subject matter experts representing 3 leading site networks as they share proven approaches to expanding site business by leveraging multi-site network models.
EGR’s Lori Wright on impact, working with experts and learning somethingnew every day
Working hard, head down and concentrating on facing the next task or challenge, it can sometimes be easy to forget how important clinical trials are in the big picture of human health and their positive impact on alleviating suffering and prolonging the quality of life.
The Network Advantage: three Models, one Goal: scaling site success
Join us for an in-depth conversation on effective strategies for growing your site within today’s evolving clinical research landscape. Hear from subject matter experts representing 3 leading site networks as they share proven approaches to expanding site business by leveraging multi-site network models.
From PI to Pioneer: Jeff Kingsley’s Mission to Modernize Clinical Trials
Joining AMRC as a founding member in 2024 was an easy decision for Chief Development Officer Jeff Kingsley and the team at Centricity Research. They understood that working with AMRC members would give sites “a big voice with sponsors and regulators,” he says.
AMRC welcomes Panthera and ObjectiveHealth as members
The Association of Multisite Research Corporations (AMRC) today announces that Panthera and ObjectiveHealth have joined the organisation, bringing total membership to 19 multisite clinical research corporations (MCRCs), up from 14 members just 12 months ago.
AMRC Response: OSTP Request for Information – Accelerating the American Scientific Enterprise
The Association of Multisite Research Corporations (AMRC) appreciates the opportunity to comment on this important Federal policy update on accelerating the American scientific enterprise. AMRC applauds any initiative to advance science and clinical trials to the benefit of patients.
Collaboration over competition: Rovia’s CEO on the future of clinical research
Patricio brings over 20 years of leadership experience in healthcare across various sectors including pharma, med device, value-based primary care, hospital, pharmacy, and DME. He earned a B.S. in Biology from Duke University and an M.B.A from Stanford University. He’s an alum of Eli Lilly, and Johnson & Johnson, where his passion for medical innovation first took root.
At the helm of AMR Clinical: Kari Delahunty’s vision for patient-first research
It was the photos that caught her eye. Vibrant images of patients, both adults and children, lining the walls of the interview room. For Kari Delahunty, those faces represented more than statistics, they were stories of lives changed through clinical trials.
The Network Advantage: defining and recognizing quality in clinical research
Join us as we present the findings of AMRC’s 2025 industry consultation on quality in clinical research and outline the steps the association will take to define and recognise quality in practice.
From expansion to infrastructure: what Tekton Research’s growth signals for MCRCs
Tekton Research’s recent announcement of two new research sites in New Carlisle, Ohio, and Englewood, New Jersey, reflects more than geographic growth. It offers a clear view into how multisite clinical research corporations (MCRCs) are evolving from collections of sites into scalable research infrastructure designed for speed, quality, and access.
